Citation: Gs. Francis et Jp. Gassler, What are 'tissue ACE inhibitors,' and should they be used instead of otherACE inhibitors?, CLEV CLIN J, 68(3), 2001, pp. 185-186
Authors:
Hunt, SA
Baker, DW
Chin, MH
Cinquegrani, MP
Feldman, AM
Francis, GS
Ganiats, TG
Goldstein, S
Gregoratos, G
Jessup, ML
Noble, RJ
Packer, M
Silver, MA
Stevenson, LW
Gibbons, RJ
Antman, EM
Alpert, JS
Faxon, DP
Fuster, V
Gregoratos, G
Jacobs, AK
Hiratzka, LF
Russell, RO
Smith, SC
Citation: Sa. Hunt et al., ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure), J AM COL C, 38(7), 2001, pp. 2101-2113
Authors:
Narayanan, S
De Stefano, N
Francis, GS
Arnaoutelis, R
Caramanos, Z
Collins, DL
Pelletier, D
Arnason, BGW
Antel, JP
Arnold, DL
Citation: S. Narayanan et al., Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b, J NEUROL, 248(11), 2001, pp. 979-986
Authors:
DiPaola, NR
Sweet, WE
Stull, LB
Francis, GS
Moravec, CS
Citation: Nr. Dipaola et al., Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: Transition from hypertrophy to failure, J MOL CEL C, 33(6), 2001, pp. 1283-1295
Citation: Th. Webb et al., Validation of the GLEAMS simulation model for estimating net nitrogen mineralisation and nitrate leaching under cropping in Canterbury, New Zealand, AUST J SOIL, 39(5), 2001, pp. 1015-1025
Citation: Gs. Francis et al., Soil degradation under cropping and its influence on wheat yield on a weakly structured New Zealand silt loam, AUST J SOIL, 39(2), 2001, pp. 291-305
Authors:
De Stefano, N
Narayanan, S
Francis, GS
Arnaoutelis, R
Tartaglia, MC
Antel, JP
Matthews, PM
Arnold, DL
Citation: N. De Stefano et al., Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability, ARCH NEUROL, 58(1), 2001, pp. 65-70
Authors:
Adams, KF
Baughman, KL
Dec, WG
Elkayam, U
Forker, AD
Gheorghiade, M
Hermann, D
Konstam, MA
Liu, P
Massie, BM
Patterson, JH
Silver, MA
Stevenson, LW
Feldman, AM
Cohn, JN
Francis, GS
Greenberg, B
Konstam, MA
Leier, C
Lorell, BH
Packer, M
Pitt, B
Silver, MA
Sonnenblick, E
Strobeck, J
Walsh, R
Yusuf, S
Citation: Kf. Adams et al., HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches, PHARMACOTHE, 20(5), 2000, pp. 495-522
Citation: M. Gheorghiade et al., Current medical therapy for advanced heart failure (Reprinted from Am Heart, vol 135, pg S231-S248, 1998), HEART LUNG, 29(1), 2000, pp. 16-32
Authors:
Pike, GB
De Stefano, N
Narayanan, S
Worsley, KJ
Pelletier, D
Francis, GS
Antel, JP
Arnold, DL
Citation: Gb. Pike et al., Multiple sclerosis: Magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images, RADIOLOGY, 215(3), 2000, pp. 824-830
Authors:
Yang, JC
Moravec, CS
Sussman, MA
DiPaola, NR
Fu, DC
Hawthorn, L
Mitchell, CA
Young, JB
Francis, GS
McCarthy, PM
Bond, M
Citation: Jc. Yang et al., Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays, CIRCULATION, 102(25), 2000, pp. 3046-3052
Authors:
Francis, GS
Anwar, F
Bank, AJ
Kubo, SH
Jessurun, J
Citation: Gs. Francis et al., Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: Observations made after implantation of left ventricular assist device, J CARD FAIL, 5(4), 1999, pp. 308-315
Authors:
Adams, KF
Baughman, KL
Dec, WG
Elkayam, U
Forker, AD
Gheorghiade, M
Hermann, D
Konstam, MA
Liu, P
Massie, BM
Patterson, JH
Silver, MA
Stevenson, LW
Feldman, AM
Cohn, JN
Francis, GS
Greenberg, B
Konstam, MA
Leier, C
Lorell, BH
Packer, M
Pitt, B
Silver, MA
Sonnenblick, E
Strobeck, J
Walsh, R
Yusuf, S
Citation: Kf. Adams et al., HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches - Heart Failure Society of America, J CARD FAIL, 5(4), 1999, pp. 357-382
Citation: Gs. Francis, Update on acute coronary syndromes - Drug therapy, medical management, andinterventional strategies, CLEV CLIN J, 66(9), 1999, pp. 560-560
Authors:
Uhm, JH
Dooley, NP
Stuve, O
Francis, GS
Duquette, P
Antel, JP
Yong, VW
Citation: Jh. Uhm et al., Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon beta-1b therapy, ANN NEUROL, 46(3), 1999, pp. 319-324